Home LiteratureArticle Details
PMID: 12376563 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.

Journal of cell science ·Vol. 115 ·No. Pt 22 ·2002-11-15 ·Pages 4317-25

David JP, Sabapathy K, Hoffmann O, Idarraga MH, Wagner EF

Abstract

Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.

MeSH Terms
Animals Apoptosis/drug effects,genetics Binding Sites/drug effects,genetics Bone Marrow Cells/drug effects,enzymology Cell Differentiation/drug effects,physiology Cells, Cultured Glycoproteins/metabolism,pharmacology Mice Mice, Knockout Mitogen-Activated Protein Kinase 8 Mitogen-Activated Protein Kinase 9 Mitogen-Activated Protein Kinases/deficiency,drug effects,genetics Monocytes/drug effects,enzymology Mutation/genetics Myeloid Progenitor Cells/drug effects,enzymology Osteoclasts/drug effects,enzymology Osteoprotegerin Phosphorylation/drug effects Proto-Oncogene Proteins c-jun/deficiency,genetics Receptors, Cytoplasmic and Nuclear/metabolism Receptors, Tumor Necrosis Factor Transcription Factor AP-1/drug effects,metabolism
Chemicals
Glycoproteins Osteoprotegerin Proto-Oncogene Proteins c-jun Receptors, Cytoplasmic and Nuclear Receptors, Tumor Necrosis Factor Tnfrsf11b protein, mouse Transcription Factor AP-1 Mitogen-Activated Protein Kinase 9 Mitogen-Activated Protein Kinase 8 Mitogen-Activated Protein Kinases
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
David Jean-Pierre
Research Institute of Molecular Pathology, Dr Bohr-Gasse 7, A-1030 Vienna, Austria.
Sabapathy Kanaga
Hoffmann Oskar
Idarraga Maria H
Wagner Erwin F
Article Info
Journal
Journal of cell science
Abbr.
J Cell Sci
ISSN
0021-9533
Published
2002-11-15
Pages
4317-25
Language
English
Region
England
NLM ID
0052457
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]